Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Current Parent Company Summary

Current Parent Company Name: Novartis
Ownership Structure: publicly traded (ticker symbol NYSE: NVS)
Headquartered in: Switzerland
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
Penalty total since 2000$2,711,277,070
Number of records: 39
Top 5 Offense Groups (Groups Defined)Penalty TotalNumber of Records
competition-related offenses$1,090,950,00010
government-contracting-related offenses$823,474,30712
healthcare-related offenses$514,508,2507
employment-related offenses$282,061,5955
financial offenses$168,5001
Top 5 Primary Offense TypesPenalty TotalNumber of Records
False Claims Act and related$823,474,30712
kickbacks and bribery$504,800,0004
off-label or unapproved promotion of medical products$501,638,2505
Foreign Corrupt Practices Act$370,800,0003
price-fixing or anti-competitive practices$215,350,0003
Notes: Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Links: Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.

For an overview of assistance this company is receiving under the CARES Act, see its Covid Stimulus Watch summary page here.

Individual Penalty Records:

Click on the company or penalty amount for more information on each case.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyPrimary Offense TypeYearAgencyPenalty Amount sort icon
Novartis Pharmaceuticals CorporationFalse Claims Act and related2020DOJ_CIVIL(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $642,000,000
Novartis Pharmaceuticals Corporationoff-label or unapproved promotion of medical products2010FDA$422,500,000
Novartis Pharmaceuticalskickbacks and bribery2015USAO$390,000,000
Novartis Hellas S.A.C.I. et al.Foreign Corrupt Practices Act2020DOJ_CRIMINAL$233,000,000
Sandoz Inc.price-fixing or anti-competitive practices2020DOJ_ANTITRUST$195,000,000
Sandoz Inc.False Claims Act and related2021DOJ_CIVIL$185,000,000
Novartis Corporationemployment discrimination2010private lawsuit-federal$175,000,000
Novartis AGForeign Corrupt Practices Act2020SEC$112,800,000
Novartis Pharmaceuticals Corp.kickbacks and bribery2020MULTI-AG$103,000,000
Novartiswage and hour violation2012private lawsuit-federal$99,000,000
Novartis Pharmaceuticals Corporationoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $88,258,694
Novartis Pharmaceuticals Corporationkickbacks and bribery2015MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $83,129,754
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporationoff-label or unapproved promotion of medical products2010FDA$72,500,000
Sandoz, Inc.False Claims Act and related2011MS-AG$30,110,618
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporationoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $29,000,000
Novartis AGForeign Corrupt Practices Act2016SEC$25,000,000
Novartis PharmaceuticalsFalse Claims Act and related2019IL-AG$21,280,356
SandozFalse Claims Act and related2009KY-AG$16,000,000
Geneva Pharmaceuticalsprice-fixing or anti-competitive practices2005MULTI-AG$15,350,000
SandozFalse Claims Act and related2013LA-AG$13,100,000
Sandoz, Inc.HHS civil monetary penalties2015HHSOIG$12,640,000
Novartis Pharmaceuticals Corporationkickbacks and bribery2020CA-AG$11,800,000
Novartis Corporation and Alcon Laboratoriesemployment discrimination2016private lawsuit-federal$8,000,000
NovartisFalse Claims Act and related2013LA-AG$7,000,000
Novartis Pharmaceuticalsoff-label or unapproved promotion of medical products2012TX-AG$6,638,250
CIBA Visionprice-fixing or anti-competitive practices2000MULTI-AG$5,000,000
Eon Labs Inc.False Claims Act and related2010DOJ_CIVIL$3,500,000
Novartis Pharmaceuticals CorporationFalse Claims Act and related2010HI-AG$3,333,333
Novartis Pharmaceuticals Corp.False Claims Act and related2012KY-AG$2,750,000
Sandoz Inc.False Claims Act and related2010ID-AG$1,650,000
Novartis Pharmaceuticals Corp.False Claims Act and related2013ID-AG$750,000
Sandoz, Inc.HHS civil monetary penalties2011HHSOIG$230,000
Chiron Corporation Ltdeconomic sanction violation2004OFAC$168,500
CHIRON CORPORATIONworkplace safety or health violation2000OSHA$90,140
Novartis Pharmaceuticalsemployment discrimination2013OFCCP$51,594
NOVARTIS PRODUCTSenvironmental violation2000EPA$13,200
NOVARTIS PHARMACEUTICALS CORPORATIONbenefit plan administrator violation2006EBSA$10,001
NOVARTIS CONSUMER HEALTH INC.workplace safety or health violation2013OSHA$6,078
NOVARTIS CONSUMER HEALTH, INC.environmental violation2000EPA$5,000
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.